Back to News
Market Impact: 0.6

Rigetti Computing Hits Quantum Milestone

RGTINDAQ
Corporate EarningsTechnology & InnovationProduct LaunchesCompany FundamentalsCorporate Guidance & OutlookRegulation & LegislationAnalyst Insights
Rigetti Computing Hits Quantum Milestone

Rigetti Computing (RGTI) reported Q2 2025 revenue of $1.8 million, down from $3.1 million year-over-year, and a net loss of $39.7 million, largely attributed to delayed U.S. National Quantum Initiative renewal and non-cash charges. Despite the revenue decline, the company achieved a significant technical milestone by launching the industry's largest multi-chip quantum computer, CPS 136Q, which halved two-qubit gate error rates to nearly 99.5% fidelity, validating its chiplet architecture. Rigetti also strengthened its liquidity to $571.6 million through a $350 million equity raise, positioning it to fund its four-year roadmap towards 'quantum advantage' and a 100+ qubit system by year-end 2025, though near-term revenue remains sensitive to government contract reauthorization.

Analysis

Rigetti Computing's second-quarter 2025 results present a dichotomy between deteriorating near-term financials and significant long-term strategic progress. Revenue declined to $1.8 million from $3.1 million year-over-year, with gross margin contracting sharply to 31% from 64%, a direct consequence of the delayed reauthorization of the U.S. National Quantum Initiative (NQI) and a less favorable revenue mix. The reported net loss of $39.7 million was driven primarily by non-cash liabilities. Juxtaposing these weak operational metrics is a major technical achievement with the launch of the CPS 136Q system, which halved two-qubit gate error rates and achieved nearly 99.5% fidelity, validating the company's proprietary multi-chiplet scaling strategy. Furthermore, Rigetti substantially de-risked its financial position by raising $350 million, bolstering its liquidity to $571.6 million in cash and equivalents with no debt. This robust balance sheet is sufficient to fund its aggressive four-year roadmap to achieve 'quantum advantage' without a material increase in operating expenses, insulating its R&D from near-term funding volatility. The company's investment case is therefore less dependent on current revenue and more on executing its technical milestones and securing future government and commercial contracts.